Mathes Company Inc. lowered its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 3.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,115 shares of the exchange traded fund’s stock after selling 325 shares during […]